For the Inventor, By the Inventor

Enter assignee name

Milpitas, CA, United States of America

Genpharm International, Inc.

USPTO Granted Patents = 28

% Expired Patents = 10.7

EPO Patents = 1

Forward Citations = 13,262

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Robert M Kay (18 out of 34 patents)

Nils Lonberg (17 out of 68 patents)

Antonius J Berns (4 out of 7 patents)

4. Anton J Berns (4 out of 5 patents)

5. Paulus J Krimpenfort (4 out of 4 patents)

6. Dianne M Fishwild (3 out of 3 patents)

7. Hein Te Riele (2 out of 2 patents)

8. Els Robanus Maandag (2 out of 2 patents)

9. Antonius Jozef Maria Berns (1 out of 1 patent)

10. Paulus Jacobus Angelinus Krimpenfort (1 out of 1 patent)

11. Rein Strijker (1 out of 7 patents)

12. Paul J Krimpenfort (1 out of 7 patents)

13. Frank R Pieper (1 out of 9 patents)

14. Jeffrey M Rosen (1 out of 5 patents)

15. Theodore K Choi (1 out of 1 patent)

Core Competencies:

Transgenic Animals

Heterologous Antibodies

Gene Targeting

Chimeric Antibodies

Mature Lymphocytic Cells

Human Antigens

Mammary Gland Targeting

Oncogenic Potential

Recombinant Yeast

Embryonic Stem Cells

Mature T-Cells

Isogenic DNA Constructs

28 patents: Sort by Forward Citations

1. 8293480 - Transgenic non-human animals for producing chimeric antibodies (2012-10-23),

2. 8231877 - Heterologous antibodies which bind human CD4 (2012-07-31),

3. 7722873 - Heterologous antibodies which bind human CD4 (2010-05-25),

4. 7084260 - High affinity human antibodies and human antibodies against human antigens (2006-08-01),

5. 7041871 - Transgenic non-human animals capable of producing heterologous antibodies (2006-05-09),

6. 6653113 - High efficiency gene targeting in mouse embryonic stem cells (2003-11-25),

7. 6384298 - Transgenic mice depleted in a mature lymphocytic cell-type (2002-05-07),

8. 6300129 - Transgenic non-human animals for producing heterologous antibodies (2001-10-09),

9. 6255458 - High affinity human antibodies and human antibodies against digoxin (2001-07-03),

10. 6023010 - Transgenic non-human animals depleted in a mature lymphocytic cell-type (2000-02-08),

11. 5877397 - Transgenic non-human animals capable of producing heterologous (1999-03-02),

12. 5874299 - Transgenic non-human animals capable of producing heterologous antibodies (1999-02-23),

13. 5814318 - Transgenic non-human animals for producing heterologous antibodies (1998-09-29),

14. 5789650 - Transgenic non-human animals for producing heterologous antibodies (1998-08-04),

15. 5789215 - Gene targeting in animal cells using isogenic DNA constructs (1998-08-04),

Genpharm International, Inc. is a biotechnology company based in Milpitas, California, specializing in the development and manufacturing of pharmaceutical products. The organization focuses on innovative solutions in the healthcare sector, particularly in the areas of generic and specialty pharmaceuticals. With a commitment to quality and compliance, Genpharm aims to enhance patient access to essential medications while advancing therapeutic options across various medical fields. Their expertise encompasses formulation development, regulatory affairs, and market access strategies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

28 Patents

#60 in Milpitas, CA

#2,846 in California

#12,009 in US

#23,262 in the World

Milpitas, CA, United States of America

Genpharm International, Inc.

Forward Citations = 13,262

16 inventors:

Robert M Kay (18 out of 34 patents)

Nils Lonberg (17 out of 68 patents)

Antonius J Berns (4 out of 7 patents)

4. Anton J Berns (4 out of 5 patents)

5. Paulus J Krimpenfort (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…